Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome

European Journal of Endocrinology

Volumn 168, Issue 1, 2013, Pages 67-74

  Hofland, Johannes ^a   De Herder, Wouter W ^a   Derks, Lieke ^a   Hofland, Leo J ^a   Van Koetsveld, Peter M ^a   De Krijger, Ronald R ^a   Van Nederveen, Francien H ^a   Horvath, Anelia ^b   Stratakis, Constantine A ^b   De Jong, Frank H ^a   Feelders, Richard A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ARGIPRESSIN; BETA CATENIN; CELL DNA; CONTRACEPTIVE AGENT; CORTICOTROPIN; GLUCAGON; GONADORELIN; HORMONE RECEPTOR; HYDROCORTISONE; HYDROXYPROGESTERONE; METOCLOPRAMIDE; PRASTERONE SULFATE; PROTIRELIN; STEROID; TESTOSTERONE;

ABDOMINAL RADIOGRAPHY; ACNE; ADRENAL CORTEX ADENOMA; ADRENAL DISEASE; ADRENALECTOMY; ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BREAST FIBROADENOMA; CANCER SCREENING; CASE REPORT; CAUCASIAN; CLITOROMEGALY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; DNA SEQUENCE; DRUG WITHDRAWAL; FEMALE; FERTILIZATION IN VITRO; HAIR LOSS; HIRSUTISM; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYPERANDROGENISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOHISTOCHEMISTRY; INFERTILITY; INTRAUTERINE INSEMINATION; LEUKOCYTE; MEDICAL HISTORY; MENARCHE; MENSTRUAL CYCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIC EXAMINATION; PHENOTYPE; PHYSICAL EXAMINATION; PREGNANCY; PRIMARY PIGMENTED NODULAR ADRENOCROTICAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL; VAGINA DISEASE; VIRILIZATION;

17-HYDROXYSTEROID DEHYDROGENASES; ADENOMA; ADRENAL CORTEX DISEASES; ADRENAL GLANDS; ADRENOCORTICAL ADENOMA; ADRENOCORTICOTROPIC HORMONE; ADULT; CUSHING SYNDROME; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; FEMALE; HUMANS; TESTOSTERONE; VIRILISM;

EID: 84871986585     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0594     Document Type: Article

References (30)

1. Carney JA, Gordon H, Carpenter PC, Shenoy BV & Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine 1985 64 270-283. (doi:10.1097/00005792-198507000-00007)
2. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS & Stratakis CA. Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex. Nature Genetics 2000 26 89-92. (doi:10.1038/79238)
3. Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nature Genetics 2006 38 794-800. (doi:10.1038/ng1809)
4. Horvath A, Mericq V & Stratakis CA. Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. New England Journal of Medicine 2008 358 750-752. (doi:10.1056/NEJMc0706182)
5. Tadjine M, Lampron A, Ouadi L, Horvath A, Stratakis CA & Bourdeau I. Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD). Clinical Endocrinology 2008 69 367-373. (doi:10.1111/j.1365-2265.2008.03273.x)
6. Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, Rene-Corail F, Stergiopoulos S, Bourdeau I et al. Mutations in regulatory subunit type 1A of cyclic adenosine 5′-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. Journal of Clinical Endocrinology and Metabolism 2009 94 2085-2091. (doi:10.1210/jc.2008-2333)
7. Stratakis CA, Kirschner LS & Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. Journal of Clinical Endocrinology and Metabolism 2001 86 4041-4046. (doi:10.1210/jc.86.9.4041)
8. Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP & Papanicolaou DA. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Annals of Internal Medicine 1999 131 585-591. (Pubitemid 29494089)
9. Groussin L, Jullian E, Perlemoine K, Louvel A, Leheup B, Luton JP, Bertagna X & Bertherat J. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. Journal of Clinical Endocrinology and Metabolism 2002 87 4324-4329. (doi:10.1210/jc.2002-020592)
10. Bourdeau I, Lacroix A, Schurch W, Caron P, Antakly T & Stratakis CA. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. Journal of Clinical Endocrinology and Metabolism 2003 88 3931-3937. (doi:10.1210/jc.2002-022001)
11. Louiset E, Stratakis CA, Perraudin V, Griffin KJ, Libe R, Cabrol S, Feve B, Young J, Groussin L, Bertherat J et al. The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits. Journal of Clinical Endocrinology and Metabolism 2009 94 2406-2413. (doi:10.1210/jc.2009-0031)
12. Lacroix A. ACTH-independent macronodular adrenal hyperplasia. Best Practice & Research. Clinical Endocrinology & Metabolism 2009 23 245-259. (doi:10.1016/j.beem.2008.10.011)
13. Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P & Lacroix A. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? Journal of Clinical Endocrinology and Metabolism 2000 85 3531-3536. (doi:10.1210/jc.85.10.3531)
14. Hsiao HP, Kirschner LS, Bourdeau I, Keil MF, Boikos SA, Verma S, Robinson-White AJ, Nesterova M, Lacroix A & Stratakis CA. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 2009 94 2930-2937. (doi:10.1210/jc.2009- 0516)
15. Lacroix A, Mircescu H & Hamet P. Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. Endocrinologist 1999 9 9-15. (doi:10.1097/00019616-199901000-00004)
16. Grotenhuis BA, Dinjens WN, Wijnhoven BP, Sonneveld P, Sacchetti A, Franken PF, van Dekken H, Tilanus HW, van Lanschot JJ & Fodde R. Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers. Journal of Pathology 2010 221 379-389. (doi:10.1002/path.2733)
17. Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C et al. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Research 2003 63 5308-5319. (Pubitemid 37139845)
18. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA & Stratakis CA. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Human Molecular Genetics 2000 9 3037-3046. (doi:10.1093/hmg/9.20.3037)
19. Kok RC, Timmerman MA,Wolffenbuttel KP, Drop SL & de Jong FH. Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X. Journal of Clinical Endocrinology and Metabolism 2010 95 994-999. (doi:10.1210/jc.2008- 1745)
20. Lamberts SW, Bons EG, Bruining HA & de Jong FH. Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells. Journal of Pharmacology and Experimental Therapeutics 1987 240 259-264. (Pubitemid 17235446)
21. Chai W, Hofland J, Jansen PM, Garrelds IM, de Vries R, van den Bogaerdt AJ, Feelders RA, de Jong FH & Danser AH. Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors? Journal of Hypertension 2010 28 1044-1053. (doi:10.1097/HJH. 0b013e328335c381)
22. Stratakis CA. New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors. Molecular and Cellular Endocrinology 2009 300 152-157. (doi:10.1016/j.mce.2008.11.010)
23. Gaujoux S, Tissier F, Ragazzon B, Rebours V, Saloustros E, Perlemoine K, Vincent-Dejean C, Meurette G, Cassagnau E, Dousset B et al. Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new association. Journal of Clinical Endocrinology and Metabolism 2011 96 E1888-E1895. (doi:10.1210/jc.2011-1433)
24. Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagnere AM, Rene-Corail F, Jullian E, Gicquel C, Bertagna X et al. Mutations of β-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Research 2005 657622-7627.
25. Durand J, Lampron A, Mazzuco TL, Chapman A & Bourdeau I. Characterization of differential gene expression in adrenocortical tumors harboring β-catenin (CTNNB1) mutations. Journal of Clinical Endocrinology and Metabolism 2011 96 E1206-E1211. (doi:10.1210/jc.2010-2143)
26. Sahut-Barnola I, de Joussineau C, Val P, Lambert-Langlais S, Damon C, Lefrancois-Martinez AM, Pointud JC, Marceau G, Sapin V, Tissier F et al. Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice. PLoS Genetics 2010 6 e1000980. (doi:10.1371/journal.pgen. 1000980)
27. Labrie F, Luu-The V, Lin SX, Simard J, Labrie C, El-Alfy M, Pelletier G & Belanger A. Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. Journal of Molecular Endocrinology 2000 25 1-16. (doi:10.1677/jme.0.0250001)
28. Hui XG, Akahira J, Suzuki T, Nio M, Nakamura Y, Suzuki H, Rainey WE & Sasano H. Development of the human adrenal zona reticularis: morphometric and immunohistochemical studies from birth to adolescence. Journal of Endocrinology 2009 203 241-252. (doi:10.1677/JOE-09-0127)
29. Hofland J, van Weerden WM, Dits NF, Steenbergen J, van Leenders GJ, Jenster G, Schroder FH & de Jong FH. Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer. Cancer Research 2010 70 1256-1264. (doi:10.1158/0008-5472.CAN-09-2092)
30. de Cremoux P, Rosenberg D, Goussard J, Bremont-Weil C, Tissier F, Tran-Perennou C, Groussin L, Bertagna X, Bertherat J & Raffin-Sanson ML. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease. Endocrine-Related Cancer 2008 15 465-474. (doi:10.1677/ERC-07-0081)